Effects of swainsonine on the humoral immune response of lipopolysaccharide

Archives of Pharmacal Research

Volumn 20, Issue 6, 1997, Pages 545-549

  Chae, Byeong Suk ^a   Ahn, Young Keun ^b   Kim, Joung Hoon ^b  

^a Woosuk University   (South Korea)

^b Wonkwang University   (South Korea)

Author keywords

Hemagglutination titer; Lipopolysaccharide; Splenic plaque forming cell; Swainsonine

Indexed keywords

EID: 0000985785     PISSN: 02536269     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02975209     Document Type: Article

References (36)

1. Bennett, R. B., Chai, J. R., Montgomery, W. D. and Cha, J. K., A short, enantioselective synthesis of (-) swainsonine. J. Am. Chem., 3, 2580-2582 (1989).
2. Broquist, H. P., The indolizidine alkaloids, slaframine and swainsonine; Contaminants in animal forages. Ann. Rev. Nutr., 5, 391-409 (1985).
3. Carswell, E. A., Old, L. J., Kassel, R. L., Green, S., Fiore, N. and Williamson, B., An endotoxin-induced serum factor that causes necrosis of tumors. Proc. Natl. Acad. Sci. U.S.A., 72, 3666-3672 (1975).
4. Coutinho, A., Gronowitz, E., Bullock, W. W. and Mller, G., Mechanism of thymus-independent immunocyte triggering; Mitogenic activation of B cells results in specific immune responses. J. Exp. Med., 139, 74-83 (1974).
5. Cunningham, A. J. and Szenberg, A., Futher improvements in the plaque technique for detecting single antibody forming cells. Immunology, 14, 599-600 (1968).
6. 2. J. Natl. Cancer Inst., 81, 1028-1033 (1989).
7. Dinarello, C. A., Biology of interleukin-1. FASEB J., 2, 108-115 (1988).
8. Elbein, A. D., Inhibitors of the biosynthesis and processing of N-linked oligosaccharide chains. Ann. Rev. Biochem., 56, 497-534 (1987).
9. Engelhardt, R., Mackensen, A., Galanos, C. and Andreesen, R., Biological response to intravenously administered endotoxin in patients with advanced cancer. J. Biol. Res. Mod., 9, 480-491 (1990).
10. Hang, L., Slack, J. H., Amundson, C., Izui, S., Theofilopoulos, A. N. and Dixon, F. J., Induction of murine autoimmune disease by chronic polyclonal B cell activation. J. Exp. Med., 157, 874-883 (1983).
11. Hino, M., Nakayama, O., Tsurumi, Y., Adachi, K., Shibata, T., Terano, H., Kohsaka, M., Aoki, H. and Imanaki, H., Studies of an immunomodulater, swainsonine I; Enhancement of immune response by swainsonine in vitro. J. Antibiot., 38, 926-935 (1985).
12. Humphries, M. J., Matsumoto, K., White, S. L., Molyneux, R. T. and Olden, K., An assessment of the effects of swainsonine on survival of mice injected with B16-F10 melanoma cells. Clin. Exp. Metast., 8, 89-102 (1990).
13. Kino, T., Inamura, N., Nakahara, K., Kiyoto, S., Goto, T., Terano, H., Kohasaka, M., Aoki, H. and Imanaka, H., Studies of an immunomodulator, swainsonine II; Effect of swainsonine on mouse immunodeficient system and experimental murine tumor. J. Antibiot., 38, 936-940 (1985).
14. Kishimoto, T., The biology of interleukin-6. Blood, 74, 1-10 (1989).
15. Litchfield, J. T. and Wilcoxon, F., Simplified method of evaluating dose-effect experiments. J. Pharmacol. Exp. Ther., 96, 99-106 (1949).
16. Marshall, N. E. and Ziegler, H. K., Lipopolysaccharide responsiveness is an important factor in the generation of optimal antigen-specific T cell responses during infection with Gram-negative bacteria. J. Immunol., 147, 2333-2339 (1991).
17. McGhee, J. R., Michalek, S. M., Moore, R. N., Mergenhagen, S. E. and Rosenstreich, D. L., Genetic control of in vivo sensitivity to lipopolysaccharide; Evidence for codominant inheritance. J. Immunol., 122, 2052-2058 (1979).
18. Mishell, B. B., Shiigi, S. M., Henry, C., Chan, E. L., North, J., Gallily, R., Slomich, M., Miller, K., Marbrook, J., Parks, D. and Good, A. H., Preparation of mouse cell suspensions. In: Mishell, B. B. and Shiigi, S. M. (Eds). "Selected Methods in Cellular Immunology". Freeman. San Francisco CA, 3, 27-32 (1980).
19. Molyneux, R. J. and James, L F., Loco intoxication: indolizidine alkaloids of spotted locoweed (Astragalus lentiginosus). Science (Wash. DC), 216, 190-191 (1982).
20. Morrison, D. C. and Ryan, J. L., Bacterial endotoxins and host immune responses. Adv. Immunol., 28, 293-304 (1979).
21. Morrison, D. C. and Ryan, J. L., Endotoxins and disease mechanisms. Ann. Rev. Med., 38, 417-432 (1987).
22. Mowat, A McI, Thomas, M. J., Mackenzie, S. and Parrott, D. V., Divergent effects of bacterial lipopolysaccharide on immunity to orally administered protein and particulate antigens in mice. J. Immunol., 58, 677-681 (1986).
23. Myc. A., Kunicka, J. E., Melamed, M. R. and Darzynkiewicz, A., Effect of swainsonine on stimulation of cell cycle progression of human lymphocytes. Cancer Res., 49, 2879-2883 (1989).
24. Olden, K., Breton, P., Grzegorzwski, K., Yasuda, Y., Gause, B. L., Oredipe, O. A., Newton, S. A. and White, S. L., The potential importance of swainsonine in therapy for cancers and immunology. Pharmac. Ther., 50, 285-290 (1991).
25. Persson, U., Lipopolysaccharide-induced suppression of the primary immune response to a thymus-dependent antigen. J. Immunol., 118, 789-796 (1977).
26. Reed, N. D., Crowle, P. K. and Ha, T., Use of mast cell deficient mice to study host parasite relationships in immuno-deficient animals. B. Ssordeted. Karger Baselip., 184-189 (1984).
27. Rietschel, E. T. and Brade, H., Bacterial endotoxins. J. Sci. American, August, 54-61 (1992).
28. Rothstein, J. L. and Schreiber, H., Synergy between tumor necrosis factor and bacterial products causes hemorrhagic necrosis and lethal shock in normal mice. Proc. Natl. Acad. Sci. U.S.A., 85, 607-611 (1988).
29. Semb, H., Peterson, J., Tavernier, J. and Olivecrona, T., Multiple effects of tumor necrosis factor on lipoprotein lipase in vivo. J. Biol. Chem., 262, 8390-8394 (1987).
30. Shalaby, M. R., Waage, A., Aarden, L. and Espevik, T., Endotoxin, tumor necrosis factor-α and interleukin-1 induce interleukin-6 production in vivo. J. Clin. Immunol. Immunopathol., 53, 488-498 (1989).
31. Skidmore, B. J., Chiller, J. M., Morrison, D. C. and Weigle, W. O., Immunologic properties of bacterial lipopolysaccharide (LPS); Correlation between the mitogenic, adjuvant and immunogenic activities. J. Immunol., 114, 770-778 (1975).
32. Taffet, S. M. and Russell, S. W., Macrophage-mediated tumor cell killing; Regulation of expression of cytolitic activity by prostaglandin E. J. Immunol., 126, 424-427 (1980).
33. Tulsiani, D. P., Harris, T. M. and Touster, O., Swainsonine inhibits the biosynthesis of complex glycoproteins by inhibition of Golgi mannosidase II. J. Biol. Chem., 257, 7936-7939 (1982).
34. Van Kampen, K. R., Rhees, R. W. and James, L. F., Locoweed poisoning in the United States. See Ref., 27, 465-471 (1978).
35. Yoshikai, Y., Maike, S., Matsumoto, T., Nomoto, K. and Takeya, K., Effect of stimulation and blockade of mononuclear phagocyte system on the delayed foot pad reation to SRBC in mice. Immunology, 38, 577-583 (1979).
36. Zarowitz, B. J., Human monoclonal antibody against endotoxin. DICP, Ann. Pharmacother., 25, 778-783 (1991).